FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells (Q46897927)

26 December 2017

title

FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells (English)

1 reference

26 December 2017

7

Timothy R Billiar

1 reference

26 December 2017

author name string

Qiuhong Zhang

1

1 reference

26 December 2017

Fengtian He

2

1 reference

26 December 2017

Ramalinga Kuruba

3

1 reference

26 December 2017

Xiang Gao

4

1 reference

26 December 2017

Annette Wilson

5

1 reference

26 December 2017

Jiang Li

6

1 reference

26 December 2017

Bruce R Pitt

8

1 reference

26 December 2017

Wen Xie

9

1 reference

26 December 2017

Song Li

10

1 reference

26 December 2017

publication date

13 November 2007

1 reference

26 December 2017

published in

Cardiovascular Research

1 reference

26 December 2017

volume

77

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

560-569

1 reference

26 December 2017

The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

beta-Arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

The AT2 receptor--a matter of love and hate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Vascular inflammation and the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Peroxisome proliferator-activated receptors and cardiovascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Identification of a nuclear receptor that is activated by farnesol metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Identification of a nuclear receptor for bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Bile acid regulation of gene expression: roles of nuclear hormone receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

The Farnesoid X Receptor (FXR) as modulator of bile acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Expression and activation of the farnesoid X receptor in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Identification of a chemical tool for the orphan nuclear receptor FXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Use of dominant negative nuclear receptors to study xenobiotic-inducible gene expression in primary cultured hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Role of FXR in regulating bile acid homeostasis and relevance for human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Inhibitory effect of the small heterodimer partner on hepatocyte nuclear factor-4 mediates bile acid-induced repression of the human angiotensinogen gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Angiotensin and its AT2 receptor: new insights into an old system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

FXR-mediated regulation of eNOS expression in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Angiotensin II type 2 receptor mediates programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Cross-talk between angiotensin II receptor types 1 and 2: potential role in vascular remodeling in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

FXR: a promising target for the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

Effects of FXR in foam-cell formation and atherosclerosis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM068

21 January 2018

Identifiers

DOI

10.1093/CVR/CVM068

1 reference

26 December 2017

PubMed ID

18006431

1 reference

26 December 2017